- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: 45.54%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | -1.50 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2022 (9) | 0.33 | 0 | 0.10 | 0 | 0.00 | 0 | 30.30 | 0 | 0.00 | 0 | 30.30 | 0 |
| 2021 (8) | -0.38 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2020 (7) | 2.42 | 0 | 0.50 | 0 | 0.00 | 0 | 20.66 | 0 | 0.00 | 0 | 20.66 | 0 |
| 2019 (6) | -0.03 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2018 (5) | 0.07 | -77.42 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2017 (4) | 0.31 | -70.48 | 0.20 | -71.43 | 0.00 | 0 | 64.52 | -3.23 | 0.00 | 0 | 64.52 | -3.23 |
| 2016 (3) | 1.05 | 47.89 | 0.70 | 0 | 0.00 | 0 | 66.67 | 0 | 0.00 | 0 | 66.67 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | -0.11 | 50.0 | 73.81 | -0.05 | 77.27 | 89.58 | -0.77 | -16.67 | 33.04 |
| 24Q2 (19) | -0.22 | 50.0 | 48.84 | -0.22 | 50.0 | 52.17 | -0.66 | -50.0 | 9.59 |
| 24Q1 (18) | -0.44 | -25.71 | -46.67 | -0.44 | -300.0 | -76.0 | -0.44 | 70.67 | -46.67 |
| 23Q4 (17) | -0.35 | 16.67 | -169.23 | -0.11 | 77.08 | -1000.0 | -1.50 | -30.43 | -554.55 |
| 23Q3 (16) | -0.42 | 2.33 | -1150.0 | -0.48 | -4.35 | -300.0 | -1.15 | -57.53 | -350.0 |
| 23Q2 (15) | -0.43 | -43.33 | -253.57 | -0.46 | -84.0 | -387.5 | -0.73 | -143.33 | -273.81 |
| 23Q1 (14) | -0.30 | -130.77 | -314.29 | -0.25 | -2400.0 | -377.78 | -0.30 | -190.91 | -314.29 |
| 22Q4 (13) | -0.13 | -425.0 | -161.9 | -0.01 | 91.67 | -104.35 | 0.33 | -28.26 | 186.84 |
| 22Q3 (12) | 0.04 | -85.71 | 108.89 | -0.12 | -175.0 | 73.33 | 0.46 | 9.52 | 177.97 |
| 22Q2 (11) | 0.28 | 100.0 | 250.0 | 0.16 | 77.78 | 180.0 | 0.42 | 200.0 | 400.0 |
| 22Q1 (10) | 0.14 | -33.33 | 163.64 | 0.09 | -60.87 | 147.37 | 0.14 | 136.84 | 163.64 |
| 21Q4 (9) | 0.21 | 146.67 | 187.5 | 0.23 | 151.11 | 171.88 | -0.38 | 35.59 | -115.64 |
| 21Q3 (8) | -0.45 | -662.5 | -400.0 | -0.45 | -125.0 | -462.5 | -0.59 | -321.43 | -122.18 |
| 21Q2 (7) | 0.08 | 136.36 | -97.15 | -0.20 | -5.26 | 67.74 | -0.14 | 36.36 | -105.09 |
| 21Q1 (6) | -0.22 | 8.33 | -266.67 | -0.19 | 40.62 | -216.67 | -0.22 | -109.05 | -266.67 |
| 20Q4 (5) | -0.24 | -166.67 | -500.0 | -0.32 | -300.0 | -740.0 | 2.43 | -8.65 | 8200.0 |
| 20Q3 (4) | -0.09 | -103.2 | 0.0 | -0.08 | 87.1 | 0.0 | 2.66 | -3.27 | 0.0 |
| 20Q2 (3) | 2.81 | 4783.33 | 0.0 | -0.62 | -933.33 | 0.0 | 2.75 | 4683.33 | 0.0 |
| 20Q1 (2) | -0.06 | -50.0 | 0.0 | -0.06 | -220.0 | 0.0 | -0.06 | -100.0 | 0.0 |
| 19Q4 (1) | -0.04 | 0.0 | 0.0 | 0.05 | 0.0 | 0.0 | -0.03 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 1.59 | -31.26 | -2.87 | 19.55 | 11.0 | 5.76 | N/A | - | ||
| 2024/9 | 2.31 | 24.36 | 12.27 | 17.96 | 12.42 | 6.48 | 1.17 | - | ||
| 2024/8 | 1.86 | -19.34 | 11.1 | 15.65 | 12.44 | 6.15 | 1.23 | - | ||
| 2024/7 | 2.31 | 16.26 | 54.83 | 13.79 | 12.63 | 6.31 | 1.2 | 主要為特用化學品及植物保護用藥去年同月的營收基期相對較低，因而本月營業收入淨額相較成長54.83%。 | ||
| 2024/6 | 1.98 | -1.83 | 59.48 | 11.48 | 6.78 | 6.08 | 1.32 | 主要為特用化學品及植物保護用藥去年同月的營收基期相對較低，因而本月營業收入淨額相較成長59.48%。 | ||
| 2024/5 | 2.02 | -2.52 | -2.79 | 9.5 | -0.1 | 5.91 | 1.35 | - | ||
| 2024/4 | 2.07 | 14.33 | 23.88 | 7.48 | 0.64 | 5.53 | 1.45 | - | ||
| 2024/3 | 1.81 | 10.04 | -19.75 | 5.4 | -6.11 | 5.4 | 1.49 | - | ||
| 2024/2 | 1.65 | -15.12 | -9.91 | 3.59 | 2.7 | 5.24 | 1.53 | - | ||
| 2024/1 | 1.94 | 17.76 | 16.57 | 1.94 | 16.57 | 6.18 | 1.3 | - | ||
| 2023/12 | 1.65 | -36.43 | -36.92 | 21.86 | -27.35 | 5.88 | 1.5 | - | ||
| 2023/11 | 2.59 | 58.37 | 5.32 | 20.21 | -26.44 | 6.29 | 1.4 | - | ||
| 2023/10 | 1.64 | -20.54 | -16.92 | 17.61 | -29.56 | 5.37 | 1.64 | - | ||
| 2023/9 | 2.06 | 23.07 | 5.06 | 15.98 | -30.64 | 5.23 | 1.76 | - | ||
| 2023/8 | 1.67 | 12.4 | -25.78 | 13.92 | -33.97 | 4.41 | 2.08 | - | ||
| 2023/7 | 1.49 | 19.75 | -35.27 | 12.24 | -34.95 | 4.81 | 1.91 | - | ||
| 2023/6 | 1.24 | -40.17 | -39.45 | 10.75 | -34.91 | 5.0 | 1.99 | - | ||
| 2023/5 | 2.08 | 24.23 | -36.53 | 9.51 | -34.26 | 6.01 | 1.65 | - | ||
| 2023/4 | 1.67 | -25.94 | -48.0 | 7.43 | -33.6 | 5.76 | 1.73 | - | ||
| 2023/3 | 2.26 | 23.53 | -34.05 | 5.75 | -27.78 | 5.75 | 1.72 | - | ||
| 2023/2 | 1.83 | 9.83 | 3.94 | 3.49 | -23.04 | 6.11 | 1.62 | - | ||
| 2023/1 | 1.67 | -36.28 | -40.12 | 1.67 | -40.12 | 6.74 | 1.47 | - | ||
| 2022/12 | 2.61 | 6.15 | 0.01 | 30.09 | 5.53 | 7.05 | 1.51 | - | ||
| 2022/11 | 2.46 | 24.92 | -19.59 | 27.47 | 6.09 | 6.4 | 1.66 | - | ||
| 2022/10 | 1.97 | 0.48 | -26.92 | 25.01 | 9.54 | 6.19 | 1.72 | - | ||
| 2022/9 | 1.96 | -13.06 | -12.99 | 23.04 | 14.42 | 6.52 | 1.61 | - | ||
| 2022/8 | 2.26 | -1.96 | 16.16 | 21.08 | 17.88 | 6.61 | 1.59 | - | ||
| 2022/7 | 2.3 | 12.02 | 27.54 | 18.82 | 18.09 | 7.63 | 1.38 | - | ||
| 2022/6 | 2.05 | -37.29 | -15.6 | 16.52 | 16.89 | 8.55 | 1.05 | - | ||
| 2022/5 | 3.28 | 1.78 | 42.14 | 14.46 | 23.65 | 9.92 | 0.91 | - | ||
| 2022/4 | 3.22 | -6.07 | 51.45 | 11.19 | 19.11 | 8.41 | 1.07 | 主要為特用化學品中除受匯率影響外，抗氧化劑及阻燃劑訂價調整或出貨增加，故本月營業收入淨額較去年同期增加51.45%。 | ||
| 2022/3 | 3.43 | 94.73 | 23.03 | 7.97 | 9.65 | 7.97 | 1.12 | - | ||
| 2022/2 | 1.76 | -36.73 | -2.38 | 4.54 | 1.34 | 7.16 | 1.24 | - | ||
| 2022/1 | 2.78 | 6.42 | 3.85 | 2.78 | 3.85 | 8.46 | 1.05 | - | ||
| 2021/12 | 2.61 | -14.65 | 29.6 | 28.51 | 3.56 | 8.37 | 0.97 | - | ||
| 2021/11 | 3.06 | 13.54 | 29.26 | 25.89 | 1.5 | 8.01 | 1.01 | - | ||
| 2021/10 | 2.7 | 19.62 | 39.28 | 22.83 | -1.34 | 6.89 | 1.18 | - | ||
| 2021/9 | 2.25 | 16.07 | 12.01 | 20.13 | -5.05 | 6.0 | 1.18 | - | ||
| 2021/8 | 1.94 | 7.63 | -2.69 | 17.88 | -6.84 | 6.18 | 1.15 | - | ||
| 2021/7 | 1.8 | -25.87 | -18.11 | 15.94 | -7.32 | 6.54 | 1.08 | - | ||
| 2021/6 | 2.43 | 5.62 | 10.98 | 14.13 | -5.73 | 6.86 | 0.88 | - | ||
| 2021/5 | 2.3 | 8.44 | 8.8 | 11.7 | -8.6 | 7.22 | 0.83 | - | ||
| 2021/4 | 2.13 | -23.69 | -10.56 | 9.39 | -12.05 | 6.71 | 0.9 | - | ||
| 2021/3 | 2.79 | 54.49 | -3.06 | 7.27 | -12.47 | 7.27 | 0.83 | - | ||
| 2021/2 | 1.8 | -32.69 | -38.12 | 4.48 | -17.46 | 6.5 | 0.93 | - | ||
| 2021/1 | 2.68 | 32.82 | 6.47 | 2.68 | 6.47 | 7.06 | 0.86 | - | ||
| 2020/12 | 2.02 | -14.88 | -22.91 | 27.53 | -15.14 | 6.32 | 1.12 | - | ||
| 2020/11 | 2.37 | 22.34 | -4.77 | 25.51 | -14.46 | 6.32 | 1.12 | - | ||
| 2020/10 | 1.94 | -3.79 | -33.38 | 23.14 | -15.34 | 5.95 | 1.19 | - | ||
| 2020/9 | 2.01 | 0.83 | -25.39 | 21.2 | -13.2 | 6.21 | 1.21 | - | ||
| 2020/8 | 2.0 | -9.42 | -27.08 | 19.19 | -11.68 | 6.39 | 1.18 | - | ||
| 2020/7 | 2.2 | 0.47 | -19.12 | 17.19 | -9.46 | 6.52 | 1.16 | - | ||
| 2020/6 | 2.19 | 3.54 | -0.49 | 14.99 | -7.85 | 6.69 | 1.09 | - | ||
| 2020/5 | 2.12 | -10.85 | -24.27 | 12.8 | -9.0 | 7.37 | 0.99 | - | ||
| 2020/4 | 2.38 | -17.29 | -10.63 | 10.68 | -5.21 | 8.16 | 0.9 | - | ||
| 2020/3 | 2.87 | -1.38 | -1.73 | 8.3 | -3.53 | 8.3 | 0.87 | - | ||
| 2020/2 | 2.91 | 15.82 | 36.66 | 5.43 | -4.46 | 8.05 | 0.9 | - | ||
| 2020/1 | 2.52 | -3.83 | -29.15 | 2.52 | -29.15 | 7.62 | 0.95 | - | ||
| 2019/12 | 2.62 | 5.14 | -4.51 | 32.44 | -6.01 | 0.0 | N/A | - | ||
| 2019/11 | 2.49 | -14.41 | -2.09 | 29.82 | -6.14 | 0.0 | N/A | - |
